The Future of Work in Pharmaceutical Product Supply - Höhl, Hans-Walter
52,95 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
payback
0 °P sammeln
  • Broschiertes Buch

Master's Thesis from the year 2024 in the subject Economy - Health Economics, grade: 1,0, Fachhochschule des bfi Wien GmbH (Master of Business Administration), course: Digital Transformation, language: English, abstract: This master's thesis examines the impact of digital transformation in the product supply domains of global pharmaceuticals companies, which are simultaneously affected by two additional factors: firstly, by novel biomedical drugs with complex manufacturing processes and logistics, and secondly, by the increasing use of AI and GenAI. These changes come with strict regulatory…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Master's Thesis from the year 2024 in the subject Economy - Health Economics, grade: 1,0, Fachhochschule des bfi Wien GmbH (Master of Business Administration), course: Digital Transformation, language: English, abstract: This master's thesis examines the impact of digital transformation in the product supply domains of global pharmaceuticals companies, which are simultaneously affected by two additional factors: firstly, by novel biomedical drugs with complex manufacturing processes and logistics, and secondly, by the increasing use of AI and GenAI. These changes come with strict regulatory oversight, but require increasing cooperation with regulators. In particular, this work investigates the dilemma between adopting future operating principles for the rapidly evolving application of digital technologies, artificial intelligence and scientific product innovations in the traditional, slowly changing and highly regulated operating area of pharmaceuticals product supply. The aim is to gain insights into the following main research question: What will the future of work look like with the concurrent introduction of digital technologies, AI and innovative biomedical modalities in the strictly regulated environment of pharmaceuticals product supply? In addition, the following subquestions are answered: What technical skills and professional competencies will be required of employees in pharmaceuticals product supply in the future? How will relationships with regulators evolve in an environment shaped by innovations in digital technologies, AI and biomedical modalities?
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Dr. Hans-Walter Höhl offers consulting services as an independent freelancer for international companies and expert networks in the areas of pharmaceutical manufacturing, supply chains and their digital transformation. After joining Bayer in 1980, Dr. Höhl developed a broad background in divisions and central functions, where he led engineering positions in process development for active ingredients and polymers. He later joined the division Pharmaceuticals, where he held leading positions in international operations, supply chain management, manufacturing strategy, operational excellence and digitalization. In his last role, he was responsible for defining the manufacturing strategy and executing the digital transformation at key sites and functions. The corresponding digital roadmap was based on the experience gained at a pilot site in Italy, which was recognized by the World Economic Forum as a digital lighthouse factory in 2019. He retired in 2020. Dr. Höhl received his diploma and